A taper, resistance training, 1.2 g/kg protein (about 0.55 g/lb), and clinical follow-up reduce the regain risk but dont guarantee weight maintenance
Fras JP, Land LF, Brown K (2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
Its important to understand that while early weight loss can be encouraging, the rate of progress may slow over time
In the HEDIS 2024 report, were the top performer in 44 care measures more than any other health care organization in the nation
There are case reports, clinical anecdotes, and small series, but no large, long-term randomized trials specifically testing microdosing schedules
The market is projected to grow strongly as new products and indication expansions broaden patient access